Effects of Dapagliflozin on Endothelial Dysfunction in Type 2 Diabetes With Established Ischemic Heart Disease (EDIFIED)

OBJECTIVES: To evaluate the effect of the sodium-glucose cotransporter 2 inhibitor (SGLT2-I) dapagliflozin on endothelial function in patients with high-risk type 2 diabetes mellitus (T2DM). METHODS: This was a prospective, double-blind, randomized, placebo-controlled, clinical trial of patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Zainordin, Nur Aisyah, Hatta, Sharifah Faradilla Wan Muhamad, Mohamed Shah, Fatimah Zaherah, Rahman, Thuhairah Abdul, Ismail, Nurhuda, Ismail, Zaliha, Abdul Ghani, Rohana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977943/
https://www.ncbi.nlm.nih.gov/pubmed/31993550
http://dx.doi.org/10.1210/jendso/bvz017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977943/
https://www.ncbi.nlm.nih.gov/pubmed/31993550
http://dx.doi.org/10.1210/jendso/bvz017

Ejemplares similares